Human Insulin Market Top Companies
Despite technological advancements, insulin accessibility remains a challenge in many regions. The Human Insulin Market faces hurdles such as high costs, uneven distribution, and limited healthcare infrastructure in low-income countries.
Efforts to expand access include government subsidies, partnerships with international organizations, and the promotion of affordable biosimilar products. Improved distribution networks and awareness programs also help ensure that patients receive timely insulin therapy. Addressing these challenges is critical for sustaining market growth and improving global diabetes management.